Bank of America
DRIO icon

Bank of America’s DarioHealth DRIO Stock Holding History

Bank of America’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,340
Closed -$165K – 7917
2022
Q2 		$165K Buy
+1,340
New +$157K ﹤0.01% 6219

Other funds holding DRIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America's DRIO Position: Q1 2026 in Review

Bank of America sold out of DarioHealth (DRIO) in Q1 2026, closing a stake of 57 shares — an estimated $649 sold.

Bank of America first reported a position in DRIO in Q2 2016 and held it in 24 quarters. The position peaked at $472K in Q4 2021. 21 funds tracked by Wall St. Rank hold DRIO as of Q1 2026.

  • Bank of America reported no remaining DarioHealth position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 57 DarioHealth shares in Q1 2026, an estimated $649.
  • Bank of America first reported a position in DarioHealth in Q2 2016 and held it in 24 quarters.
  • Bank of America's DarioHealth position peaked at $472K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held DarioHealth as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.